FCA Venture Partners
Status
ACTIVE
Global HQ
Winston-Salem, United States
Countries of investment
- USA
Investment stages
- Series A
Industries
- Health Tech
- Biotechnology
- AI
- Data Science
About
FCA Venture Partners is a distinguished venture capital and private equity firm that specializes in empowering innovative healthcare entrepreneurs. Established in 1996, the firm has built a robust reputation for fostering sustainable business growth through strategic investments and in-depth industry expertise. FCA Venture Partners is committed to partnering with visionary leaders who are dedicated to transforming the healthcare landscape, thereby enhancing patient outcomes and advancing medical innovation. Through its extensive network and resources, FCA Venture Partners aims to drive meaningful change and deliver long-term value in the healthcare sector.
FCA Venture Partners is a distinguished venture capital and private equity firm that specializes in empowering innovative healthcare entrepreneurs. Established in 1996, the firm has built a robust reputation for fostering sustainable business growth through strategic investments and in-depth industry expertise. FCA Venture Partners is committed to partnering with visionary leaders who are dedicated to transforming the healthcare landscape, thereby enhancing patient outcomes and advancing medical innovation. Through its extensive network and resources, FCA Venture Partners aims to drive meaningful change and deliver long-term value in the healthcare sector.
Investment Thesis
FCA Venture Partners focuses on investing in early stage healthcare technology and technologyenabled healthcare services companies that improve patient care, reduce costs, or increase efficiency.
Manager's Experience
With extensive experience in private equity, the fund manager has successfully navigated over 30 investments primarily in the technology and healthcare sectors across North America and Europe. They emphasize a data-driven approach, focusing on growth-stage companies, which has led to several notable exits. Their strategic style is operator-first, ensuring active engagement with portfolio companies to drive value creation. The manager's track record includes a robust portfolio that reflects a commitment to thematic investing in high-potential markets.
Team
Andrew Bouldin
Nancy S Allen
Matthew King
John Burch
Jade Beazley
Grant Blevins
George Curran
Portfolio
Virgo
Aidin
Azra AI
EvolvedMD
PrecisionGx
KODE
Casechek
Vellum
Impiricus
Diligent Pharma
PatientPartner
IHC
Payground
Thrivable
nmible
eBlu
Posterity
Credo
OhMD
Carallel
Watershed
EnableDental
identalsoft
Cylinder
GoCheckKids
OneMedPass
Health iPASS
Remedly
Spiras
Ideon
Clinical Ink
Javara
Saferide
Feedtrail
Novarus
Shiftwizard
GoCheck
Nvolve
Sondermind
RubiconMD
Chartwise
Lumere
MRA
Entrada
ProviderTrust
Kerafast
Studionow.